Lucia Sentchordi

ORCID: 0000-0002-4083-3352
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Connective tissue disorders research
  • RNA modifications and cancer
  • Genetic Syndromes and Imprinting
  • Genomics and Rare Diseases
  • Genetic factors in colorectal cancer
  • Bone health and treatments
  • Growth Hormone and Insulin-like Growth Factors
  • Peptidase Inhibition and Analysis
  • Ubiquitin and proteasome pathways
  • Osteoarthritis Treatment and Mechanisms
  • Sexual Differentiation and Disorders
  • Urological Disorders and Treatments
  • RNA Research and Splicing
  • COVID-19 Clinical Research Studies
  • Fibroblast Growth Factor Research
  • Genetics and Neurodevelopmental Disorders
  • Moyamoya disease diagnosis and treatment
  • Blood groups and transfusion
  • Cancer-related gene regulation
  • Genomic variations and chromosomal abnormalities
  • Urologic and reproductive health conditions
  • Alkaline Phosphatase Research Studies
  • Neonatal Respiratory Health Research
  • Metabolism, Diabetes, and Cancer
  • Neurogenetic and Muscular Disorders Research

Hospital Universitario La Paz
2015-2024

Hospital Universitario Infanta Leonor
2009-2024

Universidad Complutense de Madrid
2020-2024

Universidad Autónoma de Madrid
2015-2024

Institute of Molecular Genetics
2020

Instituto de Investigación de Enfermedades Raras
2017

Instituto de Salud Carlos III
2016-2017

Centro de Investigación Biomédica en Red
2016

Hospital Universitario Infanta Sofía
2016

Hospital Universitario de Guadalajara
2009

Abstract Context: Heterozygous mutations in the aggrecan gene (ACAN) cause autosomal dominant short stature with accelerated skeletal maturation. Objective: We sought to characterize phenotypic spectrum and response growth-promoting therapies. Patients Methods: One hundred three individuals (57 females, 46 males) from 20 families heterozygous ACAN were identified confirmed using whole-exome sequencing, targeted next-generation and/or Sanger sequencing. Clinical information was collected...

10.1210/jc.2016-3313 article EN The Journal of Clinical Endocrinology & Metabolism 2016-11-21

Genetic evaluation has been recognized as an important tool to elucidate the causes of growth disorders. To investigate cause short stature and determine phenotype patients with IHH mutations, including response recombinant human hormone (rhGH) therapy. We studied 17 families autosomal-dominant by using whole exome sequencing screened defects in 290 Molecular analyses were performed evaluate potential impact N-terminal variants. identified 10 pathogenic or possibly variants IHH, regulator...

10.1210/jc.2017-02026 article EN The Journal of Clinical Endocrinology & Metabolism 2017-11-15

In recent years, numerous heterozygous ACAN variants have been identified in individuals with short stature. The phenotypic spectrum includes mild to moderate stature, advanced delayed bone age, dysmorphic features, brachydactyly and/or other skeletal defects and joint pathology early adulthood which often requires surgery. However, only one multiexonic deletion has reported date, a family age childhood osteoarthritis spine deformity the father. Here, we describe 15 from 6 families...

10.1111/cen.15237 article EN Clinical Endocrinology 2025-03-24

<h3>Background</h3> Pseudohypoparathyroidism (PHP) defines a rare group of disorders whose common feature is resistance to the parathyroid hormone. Patients with PHP-Ia display additional hormone resistance, Albright hereditary osteodystrophy (AHO) and reduced Gsα activity in easily accessible cells. This form PHP associated heterozygous inactivating mutations Gsα-coding exons <i>GNAS</i>, an imprinted gene locus on chromosome 20q13.3. PHP-Ib typically have isolated lack AHO features...

10.1136/jmg.2009.071001 article EN Journal of Medical Genetics 2009-10-26

Next generation sequencing (NGS) has expanded the diagnostic paradigm turning focus to growth plate. The aim of study was determine prevalence variants in genes implicated skeletal dysplasias probands with short stature and mild anomalies.Clinical radiological data were collected from 108 anomalies.A customized dysplasia NGS panel performed. Variants classified using ACMG recommendations Sherloc. Anthropometric measurements anomalies subsequently compared those or without an identified...

10.1530/eje-21-0557 article EN European Journal of Endocrinology 2021-09-13

Processing of Precursor 1 (POP1) is a large protein common to the ribonuclease-mitochondrial RNA processing (RNase-MRP) and RNase-P (RMRP) endoribonucleoprotein complexes. Although its precise function unknown, it appears participate in assembly or stability both Numerous RMRP mutations have been reported individuals with cartilage-hair hypoplasia (CHH) but, date, only three POP1 described two families features similar anauxetic dysplasia (AD). We present further individuals, one severe...

10.1111/cge.12964 article EN Clinical Genetics 2017-01-09

Primordial dwarfism encompasses rare conditions characterized by severe intrauterine growth retardation and deficiency throughout life. Recently, three POC1A mutations have been reported in six families with the primordial dwarfism, SOFT syndrome (Short stature, Onychodysplasia, Facial dysmorphism, hypoTrichosis). Using a custom‐designed Next‐generation sequencing skeletal dysplasia panel, we identified two novel homozygous individuals dwarfism. The facial profiles are strikingly similar...

10.1002/ajmg.a.37393 article EN American Journal of Medical Genetics Part A 2015-09-16

C-type natriuretic peptide (CNP), its endogenous receptor, receptor-B (NPR-B), as well downstream mediator, cyclic guanosine monophosphate (cGMP) dependent protein kinase II (cGKII), have been shown to play a pivotal role in chondrogenic differentiation and endochondral bone growth. In humans, biallelic variants NPR2, encoding NPR-B, cause acromesomelic dysplasia, type Maroteaux, while heterozygous NPR2 (natriuretic receptor 2) NPPC precursor C), CNP, milder phenotypes. contrast, no cGKII,...

10.1136/jmedgenet-2020-107177 article EN Journal of Medical Genetics 2020-10-26

Heterozygous variants in the Indian hedgehog gene (IHH) have been reported to cause brachydactyly type A1 and mild hand feet skeletal anomalies with short stature. Genetic screening individuals stature has increasing over recent years, allowing us broaden clinical spectrum of dysplasias.The objective this article is describe genotype phenotype 16 probands heterozygous IHH.Targeted next-generation sequencing or Sanger was performed patients and/or for which genetic unknown.Fifteen different...

10.1210/clinem/dgaa218 article EN The Journal of Clinical Endocrinology & Metabolism 2020-04-20

Multiple synostosis syndrome (SYNS) is a heterogeneous group of genetic disorders mainly characterized by multiple joint due to variants in either NOG, GDF5, FGF9 or GDF6. To date, only two have been associated with SYNS, hand and feet fusion the elbow vertebral lumbar joints. Craniosynostosis was also observed one family. Here, we report clinical radiological description young girl third heterozygous variant, NM_002010.2:c.427A>T;p.(Asn143Tyr), which interestingly, located at same amino...

10.1111/cge.13876 article EN Clinical Genetics 2020-11-03

Heterozygous Indian Hedgehog gene (IHH) variants are associated with brachydactyly type A1 (BDA1). However, in recent years, numerous have been identified patients short stature and more variable forms of brachydactyly. Many located the C-terminal domain IHH (IHH-C), which lacks signaling activity but is critical for auto-cleavage activation N-terminal (IHH-N) peptide. The absence functional studies variants, particularly those IHH-C, has led to these being classified as uncertain significance (VUS).

10.1093/ejendo/lvae072 article EN European Journal of Endocrinology 2024-06-25
Coming Soon ...